跳至主要内容
临床试验/NCT03625700
NCT03625700已完成不适用

Supplementary Oxygen in Surgical and Medical Wards in the Capital Region of Denmark Evaluated by 30-day Mortality, a Retrospective Cohort Study

Hannibal Troensegaard1 个研究点 分布在 1 个国家目标入组 11,196 人开始时间: 2014年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
11,196
试验地点
1
主要终点
30- day mortality

研究概览

简要总结

This study evaluates the use and effects of supplementary oxygen in surgical and medical wards on patients admitted to a hospital in the capital region of Denmark. The population will be divided in to three groups according to their oxygenation status. The main outcome will be 30-day mortality, with secondary outcomes being Length of stay, 30-day admission to ICU, 30-day reoperations, 30-day readmission, and peak values within 30-days of C-reactive protein, S-Creatinine, Troponin.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Admission date between 1st of January 2014 to 29th of December 2014 on a hospital in the capital region of Denmark
  • Unique (first) admission in database for either:
  • Hip fracture requiring surgery
  • Chronic obstructive pulmonary disease in exacerbation
  • Acute mycardial infarction
  • Open abdominal surgery

排除标准

  • No data on saturation within 48 hours after
  • Admission (Medical patients)
  • Discharge from the post anaesthesia care unit (Surgical patients)
  • No data on primary outcome (30-day mortality)

研究组 & 干预措施

Hypoxia

Patients without chronic obstructive pulmonary disease: blood oxygen saturation <94 % irrespective of supplemental oxygen

Patients with chronic obstructive pulmonary disease: blood oxygen saturation <88% irrespective of supplemental oxygen

干预措施: Oxygen gas (Drug)

Normoxia

Patients without chronic obstructive pulmonary disease: blood oxygen saturation 94-98% in combination with supplemental oxygen OR blood oxygen saturation ≥94% without supplemental oxygen.

Patients with chronic obstructive pulmonary disease: blood oxygen saturation 88-92% in combination with supplemental oxygen OR blood oxygen saturation ≥88% without supplemental oxygen.

干预措施: Oxygen gas (Drug)

Hyperoxia

Patients without chronic obstructive pulmonary disease: blood oxygen saturation >98% in combination with supplemental oxygen

Patients with chronic obstructive pulmonary disease: blood oxygen saturation >92% in combination with supplemental oxygen

干预措施: Oxygen gas (Drug)

结局指标

主要结局

30- day mortality

时间窗: 30 days

Will be reported as a fraction of positives within the exposure group population

次要结局

  • 30- day readmission(30 days)
  • Organ markers in blood samples(30 days)
  • 30- day admission to ICU(30 days)
  • Length of stay(30 days)

研究者

发起方
Hannibal Troensegaard
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Hannibal Troensegaard

Primary investigator

University Hospital Bispebjerg and Frederiksberg

研究点 (1)

Loading locations...

相似试验